KLRS

$2.589.42%0.2224

Kalaris Therapeutics Inc (KLRS)

Kalaris Therapeutics Inc Stock (KLRS) Forecast

The Kalaris Therapeutics Inc (KLRS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.34, representing a -48.14% decrease from the current price of $2.58. The highest analyst price target is $0.8702, and the lowest is $1.81.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month KLRS Price Target

Average 3.24 (+25.36% Downside)

Is Kalaris Therapeutics Inc (KLRS) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	59.19	Neutral
STOCH(9,6)	71.23	Neutral
STOCHRSI(14)	100.00	Sell
MACD(12,26)	-0.13	Buy
ADX(14)	42.45	Buy
William %R	-8.82	Sell
CCI(14)	155.20	Buy

Buy: 3 · Sell: 2 · Neutral: 2Summary: Buy

Moving Averages

Period	Simple	Exponential
MA10	2.08 Buy	2.18 Buy
MA20	2.08 Buy	2.22 Buy
MA50	2.76 Sell	2.69 Sell
MA100	3.47 Sell	3.41 Sell
MA200	5.22 Sell	4.15 Sell

Buy: 4 · Sell: 6 · Neutral: 0Summary: Sell

According to our latest analysis, KLRS could be considered a Moderate Sell, with 17 technical analysis indicators signaling 7 Buy signals, 8 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on KLRS, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 59.19 indicates that KLRS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 71.23 indicates that KLRS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100.00 indicates that KLRS is overbought. This suggests that KLRS price is at or near the highest level relative to its recent price history.
ADX (Average Directional Index): The ADX value of 42.45 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of 155.20 indicates that KLRS is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.

Long-term KLRS price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Kalaris Therapeutics Inc financial reports and earnings history, Kalaris Therapeutics Inc (KLRS) stock could reach $20.31 by 2030, $59.42 by 2040 and $61.04 by 2050. See the projected annual prices until 2050 of the Kalaris Therapeutics Inc stock below:

Kalaris Therapeutics Inc (KLRS) is expected to reach an average price of $9.15 in 2035, with a high prediction of $24.96 and a low estimate of $9.16. This indicates an +254.20% change from the last recorded price of $2.58.
Kalaris Therapeutics Inc (KLRS) stock is projected to chart a bullish course in 2040, with an average price target of $30.71, representing an +1,089% change from its current level. The forecast ranges from a conservative $28.53 to a sky-high $59.42.
Our analysts predict Kalaris Therapeutics Inc (KLRS) to change +2,567% by 2045, soaring from $17.32 to an average price of $68.87, potentially reaching $84.72. While $17.32 is the low estimate, the potential upside is significant.
Kalaris Therapeutics Inc (KLRS) stock is expected to climb by 2050, reaching an average of $23.89, a +824.98% change from its current level. However, a wide range of estimates exists, with high and low targets of $61.04 and $24.14, respectively, highlighting the market's uncertainty.

Kalaris Therapeutics Inc Stock (KLRS) Year by Year Forecast

Kalaris Therapeutics Inc Stock (KLRS) Price Forecast for 2026

The predicted value for Kalaris Therapeutics Inc (KLRS) in 2026 is set at an average of $4.64. Estimates vary from a peak of $11.22 to a trough of $0.17, indicating an +79.65% surge from the present price of $2.58.

Month	Average	Low	High	Change from today's price
December, 2026	$1.88	$1.81	$0.8702	-27.19%

Kalaris Therapeutics Inc Stock (KLRS) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Kalaris Therapeutics Inc (KLRS) is $3.16, with a high forecast of $6.42 and a low forecast of $0.0516. This indicates an +22.20% increase from the last price of $2.58.

Month	Average	Low	High	Change from today's price
January, 2027	$5.08	$2.55	$4.33	+96.73%
February, 2027	$5.19	$4.83	$4.74	+101.00%
March, 2027	$4.85	$4.83	$4.82	+87.84%
April, 2027	$4.29	$4.47	$4.28	+66.16%
May, 2027	$2.72	$2.80	$4.19	+5.37%
June, 2027	$0.3088	$0.5512	$1.29	-88.04%
July, 2027	$1.02	$1.45	$2.54	-60.45%
August, 2027	$0.1834	$0.1116	$1.30	-92.90%
September, 2027	$3.02	$0.0516	$6.32	+16.88%
October, 2027	$4.66	$2.63	$4.96	+80.38%
November, 2027	$5.67	$3.22	$6.42	+119.48%
December, 2027	$0.8778	$0.7278	$5.97	-66.01%

Kalaris Therapeutics Inc Stock (KLRS) Price Forecast for 2028

In 2028, Kalaris Therapeutics Inc (KLRS) is projected to reach an average price of $4.31, with a high projection of $12.51 and a low estimate of $0.00363. This indicates an +66.72% rise from the last price of $2.58.

Month	Average	Low	High	Change from today's price
January, 2028	$1.95	$0.7977	$2.84	-24.58%
February, 2028	$1.02	$0.6374	$2.04	-60.60%
March, 2028	$0.7273	$0.4139	$1.86	-71.84%
April, 2028	$1.43	$0.5072	$1.47	-44.74%
May, 2028	$1.10	$0.013	$3.07	-57.52%
June, 2028	$1.35	$0.9369	$1.55	-47.85%
July, 2028	$0.5466	$0.4066	$1.51	-78.83%
August, 2028	$0.1936	$0.1335	$0.7265	-92.50%
September, 2028	$8.54	$0.00363	$4.88	+230.70%
October, 2028	$9.74	$9.25	$9.09	+277.19%
November, 2028	$12.40	$10.04	$11.74	+380.20%
December, 2028	$12.68	$12.56	$12.51	+391.06%

Kalaris Therapeutics Inc Stock (KLRS) Price Forecast for 2029

The 2029 price forecast for Kalaris Therapeutics Inc Stock (KLRS) is $5.29 on average, with a high prediction of $12.34 and a low estimate of $0.2258. This represents an +104.92% increase from the previous price of $2.58.

Month	Average	Low	High	Change from today's price
January, 2029	$12.19	$12.26	$12.34	+372.10%
February, 2029	$11.37	$11.50	$11.86	+340.36%
March, 2029	$9.42	$11.00	$11.13	+264.86%
April, 2029	$7.02	$7.27	$8.32	+171.93%
May, 2029	$7.47	$6.88	$7.17	+189.37%
June, 2029	$4.67	$6.45	$6.80	+80.96%
July, 2029	$1.73	$1.86	$5.14	-33.07%
August, 2029	$0.6837	$1.82	$2.17	-73.52%
September, 2029	$1.21	$1.24	$0.524	-52.99%
October, 2029	$2.59	$0.2258	$1.63	+0.46%
November, 2029	$2.30	$2.82	$2.71	-10.75%
December, 2029	$2.83	$2.32	$2.34	+9.40%

Kalaris Therapeutics Inc Stock (KLRS) Price Forecast for 2030

Kalaris Therapeutics Inc Stock (KLRS) is expected to reach an average price of $10.41 in 2030, with a high forecast of $20.31 and a low forecast of $1.43. This signifies an +303.19% surge from the last price of $2.58.

Month	Average	Low	High	Change from today's price
January, 2030	$2.91	$2.44	$2.41	+12.51%
February, 2030	$2.72	$2.70	$2.53	+5.16%
March, 2030	$2.50	$2.13	$1.85	-3.35%
April, 2030	$1.50	$1.64	$2.25	-42.06%
May, 2030	$1.77	$1.43	$1.52	-31.59%
June, 2030	$2.05	$1.92	$1.72	-20.73%
July, 2030	$14.92	$1.93	$13.42	+477.76%
August, 2030	$17.85	$17.31	$16.72	+591.24%
September, 2030	$20.55	$18.19	$18.12	+695.81%
October, 2030	$19.89	$20.29	$20.31	+670.27%
November, 2030	$19.68	$19.73	$19.92	+662.16%
December, 2030	$18.62	$18.68	$19.39	+621.13%

Similar to KLRS